Pages that link to "Q38246473"

The following pages link to Medical treatment of obesity: the past, the present and the future (Q38246473):

Displaying 24 items.

• Neural control of energy balance: translating circuits to therapies (Q27005992) (← links)
• The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg (Q33750634) (← links)
• Caffeine inhibits hypothalamic A1R to excite oxytocin neuron and ameliorate dietary obesity in mice (Q33851226) (← links)
• Topiramate: a review of analytical approaches for biological matrices (Q35601185) (← links)
• Plasma bile acids show a positive correlation with body mass index and are negatively associated with cognitive restraint of eating in obese patients (Q35675825) (← links)
• Cooperative interaction between leptin and amylin signaling in the ventral tegmental area for the control of food intake. (Q35749407) (← links)
• Targeting metabolic disorders by natural products (Q35830892) (← links)
• Gastrointestinal traits: individualizing therapy for obesity with drugs and devices (Q35994552) (← links)
• Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review (Q36206061) (← links)
• Ribose Accelerates Gut Motility and Suppresses Mouse Body Weight Gaining (Q36911092) (← links)
• Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations (Q38567300) (← links)
• Functional foods as potential therapeutic options for metabolic syndrome. (Q38582214) (← links)
• Circadian Clocks as Modulators of Metabolic Comorbidity in Psychiatric Disorders. (Q38611693) (← links)
• Current and cutting-edge interventions for the treatment of obese patients (Q38698582) (← links)
• Convertible visceral fat as a therapeutic target to curb obesity. (Q38769110) (← links)
• LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study (Q40632431) (← links)
• Progress and challenges in anti-obesity pharmacotherapy (Q43076027) (← links)
• European Guidelines for Obesity Management in Adults. (Q47094048) (← links)
• 2014 EASO Position Statement on the Use of Anti-Obesity Drugs (Q47129264) (← links)
• Current pharmacotherapy for obesity (Q47899412) (← links)
• Food for Thought: Reward Mechanisms and Hedonic Overeating in Obesity (Q50100220) (← links)
• Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects (Q90293757) (← links)
• Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009-2015 (Q90653808) (← links)
• Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone (Q90714102) (← links)